INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Version v1 — House Committee Amendment, #1540, INS, Draft · — · 0 words v2 — House Committee Amendment, #3003, INS, Adopted · — · 0 words v3 — Senate Committee Amendment, #3229, INS, Draft · — · 0 words v4 — Senate Committee Amendment, #3281, INS, Draft · — · 0 words v5 — Senate Committee Amendment, #3313, INS, Adopted · — · 0 words v6 — Conference Committee Report, #6237, House Proposed, Senate Adopted · — · 0 words v7 — Senate Floor Amendment, #4071, Bass, Proposed · — · 0 words v8 — House Floor Amendment, #3620, Turner, Proposed · — · 0 words v9 — House Floor Legislative Bureau Amendment, #1716, Horton, Proposed · — · 0 words v10 — HB870 Original · — · 0 words v11 — HB870 Engrossed · — · 0 words v12 — HB870 Reengrossed · — · 0 words v13 — HB870 Enrolled · — · 0 words v14 — HB870 Act 907 · — · 1.5K words Compare versions →